Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/202176 
Year of Publication: 
2017
Series/Report no.: 
JRC Working Papers on Corporate R&D and Innovation No. 07/2017
Publisher: 
European Commission, Joint Research Centre (JRC), Seville
Abstract: 
This paper investigates the relationship between the innovative activity of the top corporate R&D investors worldwide and their valuation on the financial markets. The empirical analysis is based on a sample of more than 1,500 top publicly listed Multinational Corporations (MNCs) performing a considerable share of the business investment in R&D worldwide. The main dataset covers their intellectual properties, patents and trademarks, filed between 2005 and 2012. The paper extends upon the recent literature on the links between IP assets and the firms’ financial valuation. It assesses the potential premium resulting from the interactive use of different IPRs. More importantly, it differentiates the extent to which IPRs confer a market premium to companies with respect to their industrial competitors from the extent to which within-company variations hold the key to a market premium. Finally confirming the relevance of corporate mixes of IP assets, important industrial specificities are found in the premiums granted to both individual and two-ways strategies.
Subjects: 
patents
trademarks
innovation
market valuation
within-/between-effects
JEL: 
O31
O34
L19
Document Type: 
Working Paper

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.